Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.

Survival data of patients with pancreatic carcinoma are often overestimated because of incomplete follow-up. Therefore, the aim of this study was to approach complete follow-up and to analyse survival and prognostic factors of patients who underwent surgical treatment for pancreatic adenocarcinoma. Between 1992 and 2002, 343 patients underwent surgical treatment for pancreatic adenocarcinoma. One hundred and sixty patients underwent a resection with a curative intention and 183 patients underwent bypass surgery for palliation. Follow-up was complete for 93% of patients. Median survival after resection and bypass was 17.0 and 7.5 months, and 5-year survival was 8% and 0, respectively. In multivariate analysis, tumour-positive lymph nodes, non-radical surgery, poor tumour differentiation, and tumour size were independent prognostic factors for survival after resection. For patients treated with bypass surgery, metastatic disease and tumour size independently predicted survival. In conclusion, actual survival of patients with pancreatic adenocarcinoma is disappointing compared with the actuarial survival rates reported in the literature. The independent prognostic factors for survival of patients who underwent surgical treatment for pancreatic adenocarcinoma are tumour-related.

[1]  K. Lillemoe,et al.  Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. , 1999, Annals of surgery.

[2]  Patrick M M Bossuyt,et al.  Laparoscopic Staging and Subsequent Palliation in Patients With Peripancreatic Carcinoma , 2003, Annals of surgery.

[3]  D. Gouma,et al.  Improved Results for Resection of Periampullary Adenocarcinoma , 1996, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

[4]  D. Gouma,et al.  Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. , 2001, Surgery.

[5]  M. Sierzega,et al.  Prognostic factors of long-term survival after resective procedures for pancreatic cancer. , 2001, Hepato-gastroenterology.

[6]  M. Talamini,et al.  Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. , 1997, Annals of surgery.

[7]  P. Mulder,et al.  Guidelines for the Application of Surgery and Endoprostheses in the Palliation of Obstructive Jaundice in Advanced Cancer of the Pancreas , 1994, Annals of surgery.

[8]  T. Colby,et al.  Long‐Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving? , 1995, Annals of surgery.

[9]  J. Neoptolemos,et al.  Complications of Pancreatic Cancer Resection , 2002, Digestive Surgery.

[10]  K. Campbell,et al.  Does Prophylactic Octreotide Decrease the Rates of Pancreatic Fistula and Other Complications After Pancreaticoduodenectomy?: Results of a Prospective Randomized Placebo-Controlled Trial , 2000, Annals of surgery.

[11]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[12]  D. Gouma,et al.  Complications after resection of biliopancreatic cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  A. Piccoli,et al.  Survival after resection for ductal adenocarcinoma of the pancreas , 1996, The British journal of surgery.

[14]  H. Jeekel.  Prognostic factors following curative resection for pancreatic adenocarcinoma. , 2004, Annals of surgery.

[15]  R. Parks,et al.  Prognostic factors in the palliation of pancreatic cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  K. Lillemoe,et al.  Resected Adenocarcinoma of the Pancreas - 616 Patients , 2000 .

[17]  Birgir Gudjonsson,et al.  Survival Statistics Gone Awry: Pancreatic Cancer, a Case in Point , 2002, Journal of clinical gastroenterology.

[18]  E. Rosato,et al.  Long term survival after pancreatic resection for pancreatic adenocarcinoma , 2000, American Journal of Gastroenterology.

[19]  K. Lillemoe,et al.  One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. , 1993, Annals of surgery.

[20]  S. Goodman,et al.  Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients , 1995, Annals of surgery.

[21]  S. Pedrazzoli,et al.  Current Views on Surgical Treatment of Pancreatic Cancer , 1999, Digestive Surgery.

[22]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[23]  K. Campbell,et al.  Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2: Randomized Controlled Trial Evaluating Survival, Morbidity, and Mortality , 2002, Annals of surgery.

[24]  C. Jacobi,et al.  Prognosis Factors in Carcinoma of the Head of the Pancreas , 2000, Digestive Surgery.

[25]  K. Lillemoe,et al.  Chemical Splanchnicectomy in Patients with Unresectable Pancreatic Cancer A Prospective Randomized Trial , 1993, Annals of surgery.

[26]  D. Gouma,et al.  Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region , 1995, Cancer.

[27]  P. Cotton,et al.  Randomised trial of endoscopic steriting versus surgical bypass in malignant low bileduct obstruction , 1994, The Lancet.

[28]  D. Winchester,et al.  Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.

[29]  C. Earle,et al.  Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients , 2003, Annals of surgery.

[30]  C. Garberoglio,et al.  Pancreatic adenocarcinoma: an update. , 1996, Journal of the American College of Surgeons.

[31]  D. Deziel,et al.  Prognostic Factors Associated with Resectable Adenocarcinoma of the Head of the Pancreas , 1999, The American surgeon.

[32]  K. Dhaene,et al.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. , 1998, Annals of surgery.

[33]  Dirk J Gouma,et al.  The Need for a Prophylactic Gastrojejunostomy for Unresectable Periampullary Cancer: A Prospective Randomized Multicenter Trial With Special Focus on Assessment of Quality of Life , 2003, Annals of surgery.

[34]  T. V. van Gulik,et al.  Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  L. Way,et al.  Prognostic indicators for survival after resection of pancreatic adenocarcinoma. , 1993, American journal of surgery.